Synovial Chondrosarcoma: a Single Institution Experience

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT03776942

Enrollment

Registered

2018-12-17

Start date

2018-08-07

Completion date

2019-08-31

Last updated

2020-02-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Synovial Chondrosarcoma

Brief summary

single institution cases series review of histological, radiological and clinical data

Detailed description

single institution cases series review of histological, radiological and clinical data. Investigators will retrieve from the archives of the Rizzoli institute all the cases with a histological diagnosis of synovial chondrosarcoma.

Interventions

None listed

Study design

Observational model

CASE_ONLY

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Inclusion criteria

* Male and female patients treated at Rizzoli Institute from 01 January 1982 to 31 December 2017 * Diagnosis of synovial chondrosarcoma * Age ≥ 18 years * Histological slides / formalin-fixed paraffin-embedded tissue tumor (FFPE) blocks from archive available to perform the histology analysis * Written informed consent prior to any study-specific analysis and/or data collection

Exclusion criteria

* Patients with histological diagnosis different from synovial chondrosarcoma

Design outcomes

Primary

Measure	Time frame	Description
selection and review of cases of Synovial Chondrosarcoma	baseline (Day0)	IDH1 and IDH2 analysis will be performed in order to better understand tumor characteristics and to identify the best therapeutic approach.

Countries

Italy

Outcome results